Neil Stahl, SVP Research and Development S at REGENERON PHARMACEUTICALS INC (REGN), sold 11,646 shares at $340.04 ($4.0M) on 2014-08-11, disclosed to the SEC on 2014-08-11.
Open-market sale of $4.0M REGN by SVP Research and Development S. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $339.33 | 1,617 | $549K | 13.9% |
| 2 | $340.04 | 9,829 | $3.3M | 84.4% |
| 3 | $341.27 | 200 | $68K | 1.7% |
| Total | $339.96 avg | 11,646 | $4.0M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |